U.S. Leads the Global Mechanical Ventilators Market with an Estimated Value of $6.3 Billion in 2022, China Shows Rapid Growth with an 8.5% CAGR

The “Mechanical Ventilators – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering.

The global market for Mechanical Ventilators, valued at US$14.9 billion in 2022, is projected to experience substantial growth, reaching a size of US$22.8 billion by 2030, with a compound annual growth rate (CAGR) of 5.4% during the analysis period of 2022-2030. This growth is attributed to the rising demand for intensive care and portable/transportable ventilators.

Key Findings from the Report:

  1. Intensive Care Segment to Grow at 4.9% CAGR: The intensive care segment is expected to record a 4.9% CAGR, reaching US$15.9 billion by the end of the analysis period. This growth is fueled by the increasing need for advanced life support systems in critical care settings.
  2. Strong Growth in the Portable/Transportable Segment: The portable/transportable segment is estimated to grow at a robust CAGR of 6.7% over the next eight years. This growth is driven by the demand for ventilators that provide mobility and flexibility for patient care.
  3. U.S. Market Estimated at $6.3 Billion: The Mechanical Ventilators market in the United States is estimated to be valued at US$6.3 billion in 2022. This significant market size is due to the country’s advanced healthcare infrastructure and continuous technological advancements.
  4. China’s Rapid Growth: China, the world’s second-largest economy, is forecast to experience impressive growth with a projected market size of US$1.9 billion by 2030, showcasing a CAGR of 8.5% during the analysis period. This growth is indicative of China’s increasing investment in healthcare.
  5. Global Competitive Landscape: The report features 82 key competitors in the Mechanical Ventilators market, including industry leaders such as GE HealthCare PLC, Dragerwerk AG & Co. KGaA, and Getinge AB (Getinge Group).

Economic Outlook:

The global economic outlook is showing signs of improvement, with recovery expected in the coming years. Despite challenges such as uncertainty related to the war in Ukraine and persistent inflation in developing countries, governments are making efforts to stabilize their economies. New technologies, including generative AI, applied AI, and renewables, are expected to drive economic growth and value to global GDP.

What`s New?

  • Special discussions on the global economic climate and market sentiment
  • Coverage on global competitiveness and key competitor percentage market shares
  • Market presence analysis across multiple geographies – Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and trademarked research platform
  • Complimentary updates for one year
  • Access to curated YouTube video transcripts of market sentiments shared by CEOs, domain experts and market influencers via interviews, podcasts, press statements and event keynotes

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • All Hands On Deck: The World is Scaling Up to Meet a Multifold Rise in Ventilator Demand
  • Global Number of Infections & Patients Requiring Ventilator Support
  • Amidst the COVID-19 Pandemic, Regulatory Bodies Ease Approval Process for Ventilators
  • Concerns Rise Side Effects of Using Ventilator Usage in COVID-19 Patients
  • Mechanical Ventilators: An Introduction
  • Evolution of Mechanical Ventilators: A Historical Fact File
  • Outlook
  • US Leads the Global Mechanical Ventilators Market
  • High Unmet Medical Needs Drive Developing Nations
  • Cost Benefits to Surge Growth of Non-Invasive Ventilators
  • HomeCare Ventilation Amid Rising Healthcare Costs
  • Rise in Popularity of Portable Ventilators
  • Ways to Leverage Market Potential
  • Key Market Challenges
  • Global Healthcare Spending: A Review
  • Global Healthcare Expenditure (In US$ Trillion) for the Years 2017, 2019, and 2022
  • Mechanical Ventilators – Global Key Competitors Percentage Market Share in 2022 (E)
  • Recent Market Activity
  • Competitive Market Presence – Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

  • Technological Advancements Sustain Future Market Growth
  • Select Recent Innovations
  • Automation-Enabled Innovation Continues in Mechanical Ventilators Market
  • Auto Manufacturers Join the Race to Build Ventilators
  • Startups Intensify Efforts to Develop Low Cost Ventilators amidst COVID-19 Crisis
  • Mounting Cases of COVID-19 Infections Prompt Researchers to Explore New Approaches to Reduce Need for Ventilator Assistance
  • Major Risk Factors Creating Need for Ventilation Support for COVID-19 Patients
  • Increasing Prevalence of Chronic Respiratory Diseases Drive Growth
  • Global Prevalence of COPD by Age Group: Percentage of Men and Women Affected by the Condition
  • Neonatal Ventilators Market Set for Healthy Growth
  • Global New Births (in Millions) per Annum by Geographic Region
  • Rising Incidence of Neonatal Mortality Rates to Drive Penetration Developing Countries
  • Worldwide Neonatal Mortality Rate Estimates by Region: 2000, 2005, 2020, 2015, 2019
  • Neonatal Non-Invasive Ventilation: On the Rise
  • Lung Injury: A Major Challenge for Neonatal Ventilators Market
  • Ventilator Associated Pneumonia (VAP): A Major Menace
  • Manufacturers Introduce New Features to Tackle Enduring Issue of Alarm Fatigue
  • Advances in Information Technology Enhance Monitoring Multiple Patients on Ventilation
  • High Potential for Automatic Transport Ventilators
  • Adaptive Support Ventilation: At the Forefront of Innovation
  • Aging Population: A Key Demographic Driver
  • Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
  • RESPIRATORY CONDITIONS REQUIRING MECHANICAL VENTILATORS
  • Acute Respiratory Distress Syndrome
  • Chronic Obstructive Pulmonary Disease
  • Muscular Degenerative Disease
  • Spinal Cord Injury
  • Pneumonia
  • Cystic Fibrosis
  • Asthma

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

For more information about this report visit here.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”